, /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has completed the…
Regulatory clearance enables launch of the MAVERICS Coronary Revascularization Study, advancing evaluation of the Company’s next-generation synthetic small-diameter bypass graft. , /PRNewswire/ — Medical 21, Inc., a private medical technology…
37.8% of voting rights present or represented All resolutions were approved MADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage…
Researchers examine how different seasonings shape kokumi perception in doenjang soup and influence consumer acceptance , /PRNewswire/ — Doenjang is a traditional Korean fermented soybean paste made from meju—naturally fermented…
Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments , /PRNewswire/ — Obesity is excessive fat accumulation. Despite decades of research,…
Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM , /PRNewswire/ — Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T)…
LONDON and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an…
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel…
Siemens Healthineers will utilize ALZpath’s high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer’s disease , /PRNewswire/ — ALZpath, Inc.,…
Closes $60 Million Series A Financing Round Backed by New and Existing Investors $92 Million Raised to Date Across Seed and Series A Financings , /PRNewswire/ — Link Cell Therapies…